Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the Netherlands
Abstract Background Most European countries offer human papillomavirus (HPV) vaccination through organised immunisation programmes, but the choice of vaccine varies. We compared the expected health and economic effects of the currently used bivalent vaccine, targeting HPV-16/18, and the nonavalent v...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2025-06-01
|
| シリーズ: | BMC Medicine |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s12916-025-04170-3 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
